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Abstract Objective Expectant follow-up for biopsy-proven cervical intraepithelial neoplasia
(CIN) 1 is the current recommendation for the management of this lesion. Neverthe-
less, the performance of the biopsy guided by colposcopy might not be optimal.
Therefore, this study aimed to calculate the rate of underdiagnoses of more severe
lesions in women with CIN 1 diagnosis and to evaluate whether age, lesion extent and
biopsy site are factors associated with diagnostic failure.
Methods Eighty women with a diagnosis of CIN 1 obtained by colposcopy-guided
biopsy were selected for this study. These women were herein submitted to large loop
excision of the transformation zone (LLETZ). The prevalence of lesions more severe
than CIN 1 was calculated, and the histological diagnoses of the LLETZ specimens were
grouped into two categories: “CIN 1 or less” and “CIN 2 or worse.”
Results The prevalence of lesions diagnosed as CIN 2 or worse in the LLETZ specimens
was of 19% (15/80). Three women revealed CIN 3, and 1 woman revealed a sclerosing
adenocarcinoma stage I-a, a rare type of malignant neoplasia of low proliferation,
which was not detected by either colposcopy or previous biopsy. The underdiagnosis of
CIN 2 was not associated with the women’s age, lesion extension and biopsy site.
Conclusions The standard methods used for the diagnosis of CIN 1 may underesti-
mate the severity of the true lesion and, therefore, women undergoing expectant
management must have an adequate follow-up.
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Introduction
Cervical intraepithelial neoplasia (CIN) 1 is a highly prevalent
lesion in young women, and its prevalence is decreasing with
age.1 Around 90% of the cases are associated with high-risk
human papillomavirus (HPV); however, the regression rates
of these lesions may reach up to 80%.2,3 Expectant manage-
ment with colposcopy and/or cytology follow-up has been
proposed for CIN 1, since the probability of this lesion
progressing to invasive carcinoma is low.3–6 The objective
of this clinical approach is to reduce the rate of unnecessary
surgical procedures that may involve morbidities, such as
risk of impaired fertility and obstetric outcome.7–10 Meta-
analysis studies showed that cold knife conization and large
loop excision of the transformation zone (LLETZ) are asso-
ciated with poorer obstetric outcomes related to preterm
delivery and low birthweight.10,11
Nevertheless, there is a concern with respect to the
precision of the histological diagnosis of CIN 1, since biopsy,
even if directed to themost suspected areas identified by the
colposcopist, consists of the analysis of a relatively small
tissue sample that depends on several factors, such as the
colposcopist’s skills and the interobserver variability intrin-
sic to this procedure.12 A possible error resulting from
conservative management is to diagnose CIN 1 when the
woman actually has a more severe lesion. Therefore, the
objective of this study was to re-evaluate cervical lesions in
women with a previous histological diagnosis of CIN 1
established by colposcopy-guided biopsy. The same patients
were thus submitted to LLETZ to investigate if CIN 2, CIN 3 or
cervical cancer lesions were underdiagnosed. We also eval-
uated whether age, lesion extent and biopsy site are factors
associated with diagnostic failure.
Methods
This analysis is derived from a Brazilian casuistic of rando-
mized trial to evaluate expectant management versus im-
mediate treatment for low-grade CIN performed between
January 2003 and March 2006.3 The trial included women
with previous cytology of low-grade squamous intraepithe-
lial lesion (LSIL) or atypical squamous cells of undetermined
significance (ASC-US), with a CIN 1 diagnosis revealed by
colposcopy-guided biopsy. Eighty women consecutively ran-
domized to undergo immediate treatment by LLETZ were
included in this analysis. The LLETZ was performed up to 45
days after the CIN 1 diagnosis.3
Women were selected based on their cervical smear test
routinely performed as part of a cervical cancer screening
program. Patients were excluded for any of the following:
unsatisfactory colposcopy; current pregnancy; prior therapy
for dysplasia, including medical (5-FLUROURACIL), surgical
(laser, loop electrosurgical excision procedure [LEEP]), or
cryotherapy; prior gynecologic cancer; prior pelvic radiation
therapy; other malignancies; immunosuppression due to
diseases such as AIDS, organ transplantation, or use of
immunosuppressive medications; cognitive impairment or
inability to provide written informed consent.
For the colposcopic examination, the cervix was divided
into four quadrants; the two anterior quadrants were
Resumo Objetivo O seguimento de mulheres com neoplasia intraepitelial cervical (NIC) 1
comprovada por biópsia é atualmente a recomendação de conduta para esta lesão.
Entretanto, o desempenho da biópsia guiada por colposcopia pode falhar. Assim, este
estudo teve como objetivo estimar a taxa de subdiagnóstico de lesões mais graves em
mulheres com diagnóstico de NIC 1 e avaliar se a idade, a extensão da lesão e o local da
biópsia são fatores associados à falha do diagnóstico.
Métodos Foram selecionadas 80 mulheres com diagnóstico de NIC 1 obtido por
biópsia dirigida por colposcopia. Estas mulheres foram submetidas a excisão da zona de
transformação por alça diatérmica (EZTAD). A prevalência de lesõesmais graves do que
NIC 1 foi calculada, e os diagnósticos histológicos feitos nas amostras obtidas por
EZTAD foram agrupados em duas categorias: “NIC 1 ou menos grave” e “NIC 2 ou mais
grave”.
Resultados A prevalência de lesões diagnosticadas como NIC 2 ou mais grave nas
amostras de EZTAD foi de 19% (15/80). Três mulheres apresentaram NIC 3, e uma
mulher revelou adenocarcinoma esclerosante estágio I-a, um tipo raro de neoplasia
maligna de baixa proliferação, que não foi detectado por qualquer exame de
colposcopia ou biópsia anterior. O subdiagnóstico de NIC 2 não foi associado à idade,
à extensão da lesão ou ao local da biópsia.
Conclusão Os métodos de referência utilizados para o diagnóstico da NIC 1 podem
subestimar a gravidade da lesão verdadeira e, portanto, as mulheres submetidas a
conduta expectante devem ter um seguimento adequado.
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considered as the anterior lip of the cervix, and the other two
as the posterior lip. The extension of the lesionwas recorded
according to the number of compromised quadrants of the
cervix. The site selected for the biopsywas the one identified
by the colposcopist as being the most suspicious. The exci-
sion of the transformation zone was performed using a
diathermic loop to a depth of  5 mm to include the entire
lesion identified. The histopathology of the biopsy and the
conization were analyzed by the same pathologist.
For the purpose of analysis, the LLETZ histological diag-
noses were allocated into two groups: “no neoplasia/CIN 1”
and “CIN 2 or worse (CIN 2 þ )”. The associations between
the LLETZ histological diagnosis and the age of the woman,
the extension of the lesion and the site of biopsy were
analyzed. The median age was 24 years; therefore, the
women were also grouped into “younger than 24 years”
and “24 or older”. The magnitude of the associations was
tested by odds ratios (ORs) and their respective 95% con-
fidence intervals (95%CIs). This study was approved by the
Internal Review Board of Faculdade de Ciências Médicas of
Universidade Estadual de Campinas (number 023/2003).
Results
The LLETZ confirmed that 54% (43/80) of the patients had CIN
1, and no neoplasia was found in 28% (22/80) of the speci-
mens (►Table 1). Cervical intraepithelial neoplasia 2 or
worse in the LLETZ specimens was detected in 19% (15/80)
of the women. Within this group, 3 women, aged 19, 22 and
40 (data not shown in tables), had a diagnosis of CIN 3 in the
LLETZ specimen. There was one woman for whom the LLETZ
specimen revealed a “sclerosing adenocarcinoma” stage I-a, a
rare type of malignant neoplasia of low proliferation, which
was not detected by either colposcopy or previous biopsy.
This cancer was located in the cervical canal, and the LLETZ
specimen revealed a positive endocervical margin, and the
radical hysterectomy showed no residual disease.
►Table 2 shows that lesions extending to two or more
quadrantswere present in 34% of thewomen, but thisfinding
was not significantly associated with the presence of CIN 2þ
in the LLETZ specimens. Moreover, no significant association
was found between the severity of the lesions and the age
group or the biopsy site. Biopsies were performed in the
anterior cervical lip in most cases (n ¼ 43).
Discussion
This study found 19% of CIN 2 or worse in women with
previous diagnosis of CIN 1 in colposcopy-guided biopsies.
This result suggested that the colposcopy-guided biopsy
samples are not always representative of the severity of
the lesions, and that has been observed for the colposcopic
Table 1 Distribution of histological diagnoses obtained from
LLETZ specimens for women with CIN 1 established by
colposcopy-guided biopsy
Histological diagnosis n (%)
No neoplasia 22 (27.5)
CIN 1 43 (53.8)
CIN 2 11 (13.8)
CIN 3 3 (3.8)
Malignant neoplasia 1 (1.3)
Total 80 (100)
Abbreviations: CIN, cervical intraepithelial neoplasia; LLETZ, large loop
excision of the transformation zone.
Note: Sclerosing adenocarcinoma stage I-a located at the cervical
canal.
Table 2 Association between the histological diagnosis of the LLETZ specimens with age, lesion extension and biopsy site for
women with CIN 1 established by colposcopy-guided biopsy
Histological diagnosis
No neoplasia/CIN 1
n (%)
CIN 2þ
n (%)
OR (95%CI)
Age group
< 24 years 33 (51) 10 (67) 1.93 (0.59–6.30)
 24 years 32 (49) 5 (33)
Extent of the lesiona
One quadrant 42 (66) 9 (70) 0.85 (0.19–3.52)
Two or more quadrants 22 (34) 4 (30)
Site of the biopsyb
Anterior lip 38 (60) 5 (33) 2.92 (0.79–11.29)
Posterior lip 26 (40) 10 (66)
Abbreviations: 95%CI, 95% confidence interval; CIN, cervical intraepithelial neoplasia; LLETZ, large loop excision of the transformation zone; OR, odds
ratio.
Notes: aInformation was missing for one woman with “No neoplasia/CIN 1” and two women with “CIN 2 þ ”.
bInformation was missing for one woman with “No neoplasia/CIN 1”.
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examination.13 Another issue that should be considered is
the observer variability regarding the CIN 1 histological
diagnosis, as well as the interlaboratory variability.12,14
Following a prospective two-year follow-up, the Atypical
Squamous Cells of Undetermined Significance/Low-Grade
Squamous Intraepithelial Lesions Triage Study (ALTS) re-
ported 13% of CIN 2 and CIN 3 in patients with an initial
histological diagnosis of CIN 1; 11.3% had a previous normal
colposcopy, and 11.7% had a previous negative biopsy.15
Boonlikit et al16 reported an agreement rate between biopsy
and LLETZ of 66% (Kappa ¼ 0.24; fair agreement) in women
under 50 years of age. Nevertheless, the biopsy failure rate
seems to decrease with the increasing severity of the histo-
logical diagnosis.17
In our study, we found 53.8% of agreement for CIN 1
diagnosis, and 18.7% of underdiagnosis. The remaining 27.5%
of the cases showed no neoplasia, which could be a conse-
quence of the total removal of the lesion by the colposcopy-
guided biopsy, or a regression of the lesion due to the
clearance of the HPV infection.
No associationwas found between age and the presence of
CIN 2 or worse in the LLETZ specimens. Studies have shown
that the CIN 3 prevalence is higher in older women not
enrolled in the cervical cancer screening, while age is not a
determinant factor inwomenwith previous screening tests.1
Indeed, the women in this study were previously subjected
to cervical cancer screening and, therefore, we did not find a
high prevalence rate of more severe lesions in older women,
as expected.
The extension of the lesion at colposcopy and the site of
the biopsy were not associated with CIN 2 or worse at the
LLETZ, that is, these factors were not associated with diag-
nostic failure. This finding suggests that, in the case of more
extensive lesions, the efficacy of colposcopy in selecting the
biopsy site was similar to that found when the lesions were
confined to one quadrant. Studies have shown that the
number of biopsies can increase the performance of the
colposcopy-guided biopsy. Pretorius et al18 reported 43% of
undetected high-grade lesions when performing only one
colposcopy-guided biopsy, and they suggested that diagnosis
would be more precise if random biopsies or endocervical
canal curettage were performed. Moss et al19 concluded that
single colposcopically directed punch biopsy appears to be
insufficient to exclude underlying CIN 2 or 3 in women with
an ASC-US or LSIL cytological result and minor colposcopic
findings. Increasing the number of biopsies increases the
detection rate of CIN 3, and randombiopsies from apparently
normal cervical tissue increase the chance of finding hidden
lesions.20,21
Our study diagnosed 19% of CIN 2 or worse inwomenwith
previous diagnosis of CIN 1 in colposcopy-guided biopsies,
and these findings are relevant mainly for younger women,
for whomamore conservative approachmust be considered.
However, such an approach does not seem to affect the
clinical success of the expectant management of CIN 1, as
shown by a previous clinical trial.3 Considering that the
current recommendation for CIN 1 management is follow-
up without treatment, the colposcopic examination should
reach high performance to offer a reasonable guarantee that
the woman does not have worse lesions. If the patient is
adequately followed-up, a more severe lesion might be
detected at the control visits, which could minimize the
occurrence of underdiagnosis of CIN lesions.
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